Latest News & Features
Big Pharma
Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease. 19 May 2022
Big Pharma
Natera has accused rival medical company CareDx of infringing two patents covering its “cell-free” DNA testing technology, Prospera. 17 May 2022
Big Pharma
Indian pharmaceutical company Emcure has asked a Washington court to toss a lawsuit accusing the company of stealing trade secrets related to a COVID-19 vaccine. 17 May 2022
Medtech
The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded. 17 May 2022
Generics
A subsidiary of Bristol-Myers Squibb has sued Chinese pharma company Jiangsu Hengrui Pharmaceuticals, alleging that the company’s planned generic of cancer medication Abraxane infringes a patent. 13 May 2022
Big Pharma
Novartis has convinced a Delaware court that a patent for its flagship multiple sclerosis treatment Gilenya is directed at patent-eligible matter, dismissing a challenge from Handa Pharmaceuticals that the patent is directed at natural phenomena and invalid. 12 May 2022
Big Pharma
The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone. 12 May 2022
Biotechnology
The UK government will implement the Genetic Technology Bill which promises to “remove unnecessary barriers” inherited from the European Union to bolster gene-editing technology. 11 May 2022
Biotechnology
Canadian pharmaceutical company GlycoBioSciences has sued cosmetics giant L’Oreal, alleging that the French company’s anti-wrinkle products containing hyaluronic acid infringe two patents. 10 May 2022
Americas
Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity. 10 May 2022